REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Pim Pharmaceuticals (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Pim Pharmaceuticals Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Pim Pharmaceuticals is a pharmaceutical company that offers a wide range of pharmaceutical products and solutions, with a focus on providing high-quality medicine sourced from the best ingredients and processed with the latest technology. The company is one of the first 5 corporates in Indonesia that is Halal certified.

Headquarters
Kav 21 - Kahuripan Nirwana
Sidoarjo; East Java; Postal Code: 61228

Contact Details: Purchase the PT Pim Pharmaceuticals report to view the information.

Website: http://www.pimpharma.com

Basic Information
Total Employees:
Purchase the PT Pim Pharmaceuticals report to view the information.
Outstanding Shares:
Purchase the PT Pim Pharmaceuticals report to view the information.
Registered Capital:
Purchase the PT Pim Pharmaceuticals report to view the information.
Incorporation Date:
1920
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Pim Pharmaceuticals report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
3.65%
Total operating revenue
3.65%
Total assets
1.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?